Navigation Links
SENOMYX ANNOUNCES CORPORATE UPDATE AND FIRST QUARTER FINANCIAL RESULTS
Date:4/25/2013

ich continues sales to food and beverage companies," said John Poyhonen, President and Chief Operating Officer of the Company.  "This will allow us to build our direct sales product portfolio progressively with new sweet flavor modifiers."

Concurrent with the amendment, Senomyx and Firmenich entered into a supply agreement under which Firmenich has agreed to supply Senomyx with commercial quantities of certain ingredients from the Sweet Taste Program. "Firmenich is a world-class flavor ingredient manufacturer that already has experience with Senomyx's modifiers," Poyhonen noted.  "We believe this arrangement will streamline the launch of our direct sales strategy without Senomyx having to incur the cost of sourcing and establishing manufacturing capabilities at this time.  We expect that Firmenich will manufacture commercial quantities of our S9632 sucrose modifier by the end of 2013.  We currently anticipate Senomyx's first direct sale of S9632 in late-2013 or early-2014."

"We continue to make significant advancements in our Sweet Taste Program," Snyder said.  "We have used Senomyx's proprietary technologies to discover and develop multiple sucrose modifiers, each of which has distinct characteristics that enable the modifier to restore the desired sweet taste in a variety of sugar-reduced products.  Our technology also led to S617, a modifier of both sucrose and high fructose corn syrup (HFCS) that is currently in the development phase.  Most recently, we have identified a number of additional promising fructose modifiers that demonstrated the ability to restore the taste of product prototypes with reduced HFCS.  We believe that having a portfolio of modifiers for HFCS, a widely used sweetener, will expand the product applications that we can address and increase the value of our sweet modifier offerings."

Commercialization Updates:Senomyx Direct Sales Initiative:  Under the Company's new dir
'/>"/>

SOURCE Senomyx
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Senomyx To Webcast Corporate Presentation At The 25th Annual ROTH Conference
2. Senomyx Announces Fourth Quarter And Full Year 2012 Financial Results And Initiation Of New Direct Sales Strategy
3. SENOMYX AND FIRMENICH ANNOUNCE AMENDMENT OF THEIR SWEET TASTE PROGRAM AGREEMENT
4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 12TH ANNUAL NEEDHAM HEALTHCARE CONFERENCE
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
6. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
7. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
8. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
9. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
10. WuXi PharmaTech Announces Third-Quarter 2011 Results
11. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... --  Synageva BioPharma Corp. (NASDAQ: ... for rare disorders, today reported 2014 full year ... objectives, and financial guidance.  Synageva,s management team will ... EST to review the financial results and provide ... call by telephone, please dial (877) 445-4603 for ...
(Date:2/26/2015)... 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured ... against Genewiz Inc. in excess of $10 million. The ... trade secrets, and that it improperly hired one or ... order denying motions for judgment notwithstanding the verdict, a ...
(Date:2/26/2015)... IL (PRWEB) February 26, 2015 Already ... its gauging line by expanding its Length Gauge offerings ... ACANTO gauges. , Specifically, HEIDENHAIN’s pencil probe-style ... improved force specification. Two new 1Vpp, 12mm stroke ... lower force applications. One is a variant with a ...
(Date:2/26/2015)... 2015 Regis Technologies announced new ... oncology drug substances. , Regis Technologies is proud to ... Potent Compound Suite (PCS) for 2015. , Regis is ... cGMP facility in Morton Grove, Illinois. The PCS addition ... compounds up to about one kilogram per batch. ...
Breaking Biology Technology:Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2Regis Extends cGMP Services to Oncology Market 2
... Boston Scientific Corporation (NYSE: BSX ) ... ® Clinical Science program, which demonstrated that defibrillator ... in mortality due to defibrillator shock.  Instead, the authors ... is not attributed to the defibrillator shock itself, but ...
... May 5, 2011 Momentum is building ... (ErgoExpo), the largest ergonomics event in the nation, held ... 2, 2011. The expo has already grown over 10% ... and exhibitors increasing the size of their exhibit space. ...
... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... commercialization of products for central nervous system disorders, today ... ended March 31, 2011. "We are very ... date in 2011," said Mihael H. Polymeropoulos, M.D., President ...
Cached Biology Technology:ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase from Device Shock 2ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase from Device Shock 3ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase from Device Shock 42011 National Ergonomics Conference and Expo (ErgoExpo) Announces HP, CDC, VPPPA Leaders to Keynote; Expo on Pace to Sell Out 2Vanda Pharmaceuticals Reports First Quarter 2011 Results 2Vanda Pharmaceuticals Reports First Quarter 2011 Results 3Vanda Pharmaceuticals Reports First Quarter 2011 Results 4Vanda Pharmaceuticals Reports First Quarter 2011 Results 5Vanda Pharmaceuticals Reports First Quarter 2011 Results 6Vanda Pharmaceuticals Reports First Quarter 2011 Results 7Vanda Pharmaceuticals Reports First Quarter 2011 Results 8
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the ... report to their offering. , The ... individual is who she/he is claiming to be, and for ... unique physical characteristics, such as fingerprint, hand or palm print, ...
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading source ... launch of its new website design. "When we ... infancy", says Peter O,Neill , founder and CEO of ... industry needs involvement from the key players on a very ...
(Date:1/22/2015)... 2015 Technology Showcase, Hall E -   EyeLock Inc. ... announced it will showcase its EyeLock ID technology integrated in ... of Energy,s Oak Ridge National Laboratory (ORNL) at ... iris identity authentication technology is being used to validate the ...
Breaking Biology News(10 mins):Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... WASHINGTON (20 April 2010) -- Ultrasound pioneer Gerald J. ... the highest award in the engineering profession on ... (AAES). Posakony,s pioneering contributions to the fields ... were recognized during AAES, 31st annual awards ceremony at ...
... today new study results showing that when and how ... life has vital implications to a child,s developmental, diagnostic, ... Journal of Autism and Developmental Disorders (Epub ahead ... warning signs may actually be at lower risk for ...
... Researchers have made an important breakthrough in the use of ... cells an innovative technology that could significantly reduce the ... The advance was just reported in Current Applied Physics ... and Yeungnam University in Korea. This is one of ...
Cached Biology News:Ultrasound pioneer receives highest award in engineering profession 2Ultrasound pioneer receives highest award in engineering profession 3Ultrasound pioneer receives highest award in engineering profession 4Ultrasound pioneer receives highest award in engineering profession 5Ultrasound pioneer receives highest award in engineering profession 6Study provides new insights into the implications of autism onset patterns 2Study provides new insights into the implications of autism onset patterns 3Advance made in thin-film solar cell technology 2Advance made in thin-film solar cell technology 3
BD BioCoat Gelatin 100 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of gelatin....
The F40 piston assembly is supplied as two assemblies to service one F40 pump of a BioLogic DuoFlow workstation....
... used as an internal standard for the ... mass spectrometry. 5-OxoETE is a polyunsaturated keto ... in human neutrophils. It stimulates cytosolic calcium ... 2 nM. 5-OxoETE selectively stimulates the migration ...
...
Biology Products: